BHI Bodypure Tablet

Manufacturer: MediNatura Inc
Effective date: 2022-07-11
Label type: HUMAN OTC DRUG LABEL
Version: 6
Source: legacy-cache
Hydrated at: 2026-08-01 21:57:16

Label at a glance#

ProductBHI Bodypure

Active ingredient.ALPHA.-LIPOIC ACID, AVENA SATIVA FLOWERING TOP, BERBERIS VULGARIS ROOT BARK, CAFFEINE, CHOLESTEROL, JUGLANS REGIA FLOWERING TOP, STRYCHNOS NUX-VOMICA SEED, KEROSENE, FRANGULA PURSHIANA BARK, RICINUS COMMUNIS SEED, SOLIDAGO VIRGAUREA FLOWERING TOP, URTICA URENS, VIOLA TRICOLOR, ALCOHOL, X-RAY EXPOSED (1000 RAD)

Label structure8 sections

Indications and uses

For the temporary relief of minor fatigue, headache, bloating

Dosage and administration

At first sign of symptoms: Adults and children 12 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Standard dosage: Adults and children 12 years and older: Take 1-2 tablets every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 12, consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Each tablet contains: a-Lipoicium acidum 3X, 6X, 8X, *Avena sativa 3X, *Berberis vulgaris 6X, *Caffeinum 6X, *Cholesterinum 10X, *Juglans regia 6X, *Nux vomica 30X, *Petroleum 12X, *Rhamnus purshiana 6X, *Ricinus communis 3X, *Solidago virgaurea 4X, *Urtica urens 6X, *Viola tricolor 4X, *X-Ray 12X 18.8 mg each.

*Natural Ingredients

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: **Dextrose, ** Lactose, Magnesium Stearate, **Maltodextrin
**contains one or more of these ingredients.

PURPOSE

OTC - PURPOSE SECTION

Cleansing Tablets

Relieves:

• Fatigue

• Headache

• Bloating

USES

INDICATIONS & USAGE SECTION

For the temporary relief of minor fatigue, headache, bloating

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

At first sign of symptoms:Adults and children 12 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage.

Standard dosage: Adults and children 12 years and older: Take 1-2 tablets every 4 to 6 hours. Do not exceed 12 tablets in 24 hours.

For children under 12, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow.

WARNINGS

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Body Pure or any of its ingredients exists.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BHI Bodypure Tablet.jpg

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62795-1003-2	EA - Each	62795-1003	a37d9534-f91a-4102-b3fb-1591f63a1b3f	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
.ALPHA.-LIPOIC ACID	ACTIVE INGREDIENT	73Y7P0K73Y	1
ALCOHOL, X-RAY EXPOSED (1000 RAD)	ACTIVE INGREDIENT	6PRJ93602P	1
AVENA SATIVA FLOWERING TOP	ACTIVE INGREDIENT	MA9CQJ3F7F	1
BERBERIS VULGARIS ROOT BARK	ACTIVE INGREDIENT	1TH8Q20J0U	1
CAFFEINE	ACTIVE INGREDIENT	3G6A5W338E	1
CHOLESTEROL	ACTIVE INGREDIENT	97C5T2UQ7J	1
FRANGULA PURSHIANA BARK	ACTIVE INGREDIENT	4VBP01X99F	1
JUGLANS REGIA FLOWERING TOP	ACTIVE INGREDIENT	3BA2N709NG	1
KEROSENE	ACTIVE INGREDIENT	1C89KKC04E	1
RICINUS COMMUNIS SEED	ACTIVE INGREDIENT	7EK4SFN1TX	1
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE INGREDIENT	5405K23S50	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE INGREDIENT	269XH13919	1
URTICA URENS	ACTIVE INGREDIENT	IHN2NQ5OF9	1
VIOLA TRICOLOR	ACTIVE INGREDIENT	9Q24RAI43V	1
.ALPHA.-LIPOIC ACID	ACTIVE MOIETY	73Y7P0K73Y	1
ALCOHOL, X-RAY EXPOSED (1000 RAD)	ACTIVE MOIETY	6PRJ93602P	1
AVENA SATIVA FLOWERING TOP	ACTIVE MOIETY	MA9CQJ3F7F	1
BERBERIS VULGARIS ROOT BARK	ACTIVE MOIETY	1TH8Q20J0U	1
CAFFEINE	ACTIVE MOIETY	3G6A5W338E	1
CHOLESTEROL	ACTIVE MOIETY	97C5T2UQ7J	1
FRANGULA PURSHIANA BARK	ACTIVE MOIETY	4VBP01X99F	1
JUGLANS REGIA FLOWERING TOP	ACTIVE MOIETY	3BA2N709NG	1
KEROSENE	ACTIVE MOIETY	1C89KKC04E	1
RICINUS COMMUNIS SEED	ACTIVE MOIETY	7EK4SFN1TX	1
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE MOIETY	5405K23S50	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE MOIETY	269XH13919	1
URTICA URENS	ACTIVE MOIETY	IHN2NQ5OF9	1
VIOLA TRICOLOR	ACTIVE MOIETY	9Q24RAI43V	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

BHI Bodypure
.ALPHA.-LIPOIC ACID, AVENA SATIVA FLOWERING TOP, BERBERIS VULGARIS ROOT BARK, CAFFEINE, CHOLESTEROL, JUGLANS REGIA FLOWERING TOP, STRYCHNOS NUX-VOMICA SEED, KEROSENE, FRANGULA PURSHIANA BARK, RICINUS COMMUNIS SEED, SOLIDAGO VIRGAUREA FLOWERING TOP, URTICA URENS, VIOLA TRICOLOR, and ALCOHOL, X-RAY EXPOSED (1000 RAD)
.ALPHA.-LIPOIC ACID
AVENA SATIVA FLOWERING TOP
BERBERIS VULGARIS ROOT BARK
CAFFEINE
CHOLESTEROL
JUGLANS REGIA FLOWERING TOP
STRYCHNOS NUX-VOMICA SEED
KEROSENE
FRANGULA PURSHIANA BARK
RICINUS COMMUNIS SEED
SOLIDAGO VIRGAUREA FLOWERING TOP
URTICA URENS
VIOLA TRICOLOR
ALCOHOL, X-RAY EXPOSED (1000 RAD)
LACTOSE
MAGNESIUM STEARATE
MALTODEXTRIN
DEXTROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
62795-1003	62795-1003-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
.ALPHA.-LIPOIC ACID	73Y7P0K73Y	ACTIB
AVENA SATIVA FLOWERING TOP	MA9CQJ3F7F	ACTIB
BERBERIS VULGARIS ROOT BARK	1TH8Q20J0U	ACTIB
CAFFEINE	3G6A5W338E	ACTIB
CHOLESTEROL	97C5T2UQ7J	ACTIB
JUGLANS REGIA FLOWERING TOP	3BA2N709NG	ACTIB
STRYCHNOS NUX-VOMICA SEED	269XH13919	ACTIB
KEROSENE	1C89KKC04E	ACTIB
FRANGULA PURSHIANA BARK	4VBP01X99F	ACTIB
RICINUS COMMUNIS SEED	7EK4SFN1TX	ACTIB
SOLIDAGO VIRGAUREA FLOWERING TOP	5405K23S50	ACTIB
URTICA URENS	IHN2NQ5OF9	ACTIB
VIOLA TRICOLOR	9Q24RAI43V	ACTIB
ALCOHOL, X-RAY EXPOSED (1000 RAD)	6PRJ93602P	ACTIB
LACTOSE	J2B2A4N98G	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MALTODEXTRIN	7CVR7L4A2D	IACT
DEXTROSE	IY9XDZ35W2	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 75 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SUSPENSION, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	INSERT / VAGINAL		69 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE / ORAL		127 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TROCHE / ORAL		315 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SYSTEM / INTRAVITREAL	0.02 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, EXTENDED RELEASE / ORAL		173 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CREAM / TOPICAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		9 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FOR SUSPENSION / ORAL		131 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	RING / VAGINAL		2 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED / ORAL		96 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, COATED / ORAL		184 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE / ORAL		629 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	PELLET / ORAL		24 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SUSPENSION / ORAL		64 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE, FOR SUSPENSION / ORAL		14 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	WAFER / ORAL	66 mg		Exact identifier — unii candidate 39 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
e675e202-1eb8-4d16-b6bd-477631366d7a			e9af8c76-c6ed-40a6-8b54-817a71d5705e	2022-07-11	Warnings	Exact identifier spl id: e675e202-1eb8-4d16-b6bd-477631366d7a spl set id: e9af8c76-c6ed-40a6-8b54-817a71d5705e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.